Radka Bužgová1, Darja Jarošová2, Erika Hajnová3. 1. Department of Nursing and Midwifery, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava 700 30, Czech Republic. Electronic address: radka.buzgova@osu.cz. 2. Department of Nursing and Midwifery, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava 700 30, Czech Republic. Electronic address: darja.jarosova@osu.cz. 3. Clinic of Oncology, University Hospital Ostrava, Czech Republic; Department of Nursing and Midwifery, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava 700 30, Czech Republic. Electronic address: erika.hajnova@fno.cz.
Abstract
PURPOSE: The study aimed at assessing the presence of anxiety and depression in cancer inpatients receiving palliative care at an oncology department using the Hospital Anxiety and Depression Scale (HADS) and determining whether anxiety and depression contribute to a lower quality of life controlled for pain and illness severity. METHOD: This cross-sectional study comprised 225 advanced cancer inpatients (a mean age of 65.1 years). Data were collected with the HADS, EORTC QLQ-C30 and Karnofsky Performance Status scale. RESULTS: Anxiety (HADS-a ≥8) was found in 33.9% and depression (HADS-d ≥8) in 47.6% of patients. Higher anxiety scores were observed in patients living with a partner (p = 0.042) and non-religious patients (p = 0.045). Correlations were found between anxiety, depression and all quality of life dimensions (r = 0.31-0.63). Multiple regression analysis showed that anxiety and depression contribute to lower physical and emotional functioning. Patients with anxiety (HADS-a ≥8) and depression (HADS-d ≥8) reported a lower total quality of life (p < 0.01). CONCLUSION: Management of anxiety and depression in cancer patients receiving palliative care may contribute to improvement in certain quality of life dimensions.
PURPOSE: The study aimed at assessing the presence of anxiety and depression in cancer inpatients receiving palliative care at an oncology department using the Hospital Anxiety and Depression Scale (HADS) and determining whether anxiety and depression contribute to a lower quality of life controlled for pain and illness severity. METHOD: This cross-sectional study comprised 225 advanced cancer inpatients (a mean age of 65.1 years). Data were collected with the HADS, EORTC QLQ-C30 and Karnofsky Performance Status scale. RESULTS:Anxiety (HADS-a ≥8) was found in 33.9% and depression (HADS-d ≥8) in 47.6% of patients. Higher anxiety scores were observed in patients living with a partner (p = 0.042) and non-religious patients (p = 0.045). Correlations were found between anxiety, depression and all quality of life dimensions (r = 0.31-0.63). Multiple regression analysis showed that anxiety and depression contribute to lower physical and emotional functioning. Patients with anxiety (HADS-a ≥8) and depression (HADS-d ≥8) reported a lower total quality of life (p < 0.01). CONCLUSION: Management of anxiety and depression in cancerpatients receiving palliative care may contribute to improvement in certain quality of life dimensions.
Authors: Joseph A Greer; Jamie Jacobs; Nicole Pensak; James J MacDonald; Charn-Xin Fuh; Giselle K Perez; Alina Ward; Colleen Tallen; Alona Muzikansky; Lara Traeger; Frank J Penedo; Areej El-Jawahri; Steven A Safren; William F Pirl; Jennifer S Temel Journal: Oncologist Date: 2019-01-25
Authors: Malathi G Nayak; Anice George; M S Vidyasagar; Stanley Mathew; Sudhakar Nayak; Baby S Nayak; Y N Shashidhara; Asha Kamath Journal: Indian J Palliat Care Date: 2017 Oct-Dec
Authors: Eduard Falk; Daniel Schlieper; Patrick van Caster; Matthias J Lutterbeck; Jacqueline Schwartz; Joachim Cordes; Ina Grau; Peter Kienbaum; Martin Neukirchen Journal: BMC Palliat Care Date: 2020-01-03 Impact factor: 3.234